Long-term pulmonary consequences in survivors with bronchopulmonary dysplasia

V K Bhutani1, S Abbasi

  • 1University of Pennsylvania School of Medicine, Philadelphia.

Clinics in Perinatology
|September 1, 1992
PubMed

Insights

Infants with bronchopulmonary dysplasia (BPD) and even those without BPD who received mechanical ventilation show abnormal airway function. Early pulmonary follow-up can reduce respiratory issues and hospital readmissions in high-risk infants.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Respiratory Medicine

Background:

  • Abnormal airway function is well-documented in infants with bronchopulmonary dysplasia (BPD).
  • Residual pulmonary dysfunction persists into childhood and adulthood, even in preterm infants without BPD who underwent mechanical ventilation.
  • Extremely compliant airways in very low birth weight infants increase susceptibility to barotrauma during neonatal mechanical ventilation.

Purpose of the Study:

  • To highlight the long-term consequences of airway injury in infants, particularly those with BPD.
  • To emphasize the need for minimizing airway barotrauma through optimized ventilatory support post-surfactant therapy.
  • To advocate for comprehensive pulmonary follow-up services alongside neurodevelopmental services for high-risk infants.

Main Methods:

  • Review of existing clinical and pulmonary function test evidence regarding airway function in infants.
  • Analysis of long-term outcomes in preterm neonates, including those with and without BPD.
  • Consideration of the impact of mechanical ventilation and surfactant therapy on airway health.

Main Results:

  • Established evidence of abnormal airway function in infants with BPD, persisting into later life.
  • Demonstrated residual pulmonary dysfunction in mechanically ventilated preterm infants, even without a BPD diagnosis.
  • Identified airway barotrauma as a significant risk factor for long-term airway dysfunction in vulnerable infants.

Conclusions:

  • Airway injury during the neonatal period can lead to lasting abnormal airway function in infants.
  • Reducing ventilator-induced barotrauma is crucial for minimizing long-term respiratory morbidity.
  • Integrating pulmonary function testing into neonatal follow-up can improve outcomes and reduce hospital readmissions for infants at risk.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...